{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-295368","form_type":"8-K","ticker":"AURA","cik":"0001501796","company_name":"Aura Biosciences, Inc.","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.887856+00:00","generated_at":"2026-06-21T11:37:28.421209+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aura Biosciences updates corporate presentation; no new material information disclosed","bullets":["Aura Biosciences posted an updated corporate presentation for investor and analyst meetings as of November 30, 2022.","The presentation update does not include any new financial results, clinical trial data, or material business changes.","No specific numbers, dates, or events were provided in the filing text to analyze."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-295368","json":"https://secwatch.observer/filing/0001193125-22-295368.json","markdown":"https://secwatch.observer/filing/0001193125-22-295368.md","text":"https://secwatch.observer/filing/0001193125-22-295368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/0001193125-22-295368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501796/000119312522295368/d378294d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:37:28.421209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}